Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-04-14
1998-12-01
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549 57, 549 58, A01N 4312, C07D33356
Patent
active
058439846
ABSTRACT:
Sulfated benzothiophenes of the formula I ##STR1## wherein R.sup.1 is hydrogen, hydroxy, C.sub.1 -C.sub.4 alkoxy, --OCOO(C.sub.1 -C.sub.6 alkyl), --OCO(C.sub.1 -C.sub.6 alkyl), --OCOAr wherein Ar is phenyl or optionally substituted phenyl, --OSO.sub.2 (C.sub.4 -C.sub.6 straight chain alkyl), or --OSO.sub.3 H;
R.sup.2 is R.sup.1, Cl or F; with the proviso that at least one of R.sup.1 or R.sup.2 is --OSO.sub.3 H;
R.sup.3 is 1-piperidinyl, 1-pyrrolidinyl, methyl-1-pyrrolidinyl, dimethyl-1-pyrrolidino, 4-morpholino, dimethylamino, diethylamino, diisopropylamino, or 1-hexamethyleneimino; and
n is 2 or 3;
or a pharmaceutically acceptable salt or solvate thereof.
REFERENCES:
patent: 4600714 (1986-07-01), Gaitanopoulos et al.
patent: 5482949 (1996-01-01), Black et al.
patent: 5605924 (1997-02-01), Black et al.
Gilbert E.E., "The Reactions of Sulfur Trioxide . . .", Chem. Rev., vol. 62 (Oct. 1962), No. 5, pp. 549-581.
Biological Abstracts, vol. 89, No. 5, issued 1989, Lumsden et al. "Estrogeneic action of tamoxifen in women treated with LHRH agonists: Lack of shrinkage of uterine fibroids" see abstr. No. 52267, Fertil Steril, 52(6)924-929.
Medline No. 94260928, issued 1993, insua et al. "Postmenopause, plasma lipoproteins and hormone replacement therapy", abstr. 07780888, Medicina 53 (4) p364-70.
Medline No. 91146429, issued 1990, Schwandt, "Triglyceride rich lipoproteins and atherosclerosis" Abstr. 06562347, Drugs 40 suppl 1, p38-41.
Embase No. 95283951, issued 1995, Oparil, "Hypertension in postmenopausal women: Pathophysiology and management" Abstr. 9733793, Current Opinion in Nephrology and Hypertension, vol. 4, 438-442.
Biosis No. 85006817, issued 1987, Robinson et al. "Reversal of the antitumor effects of tamoxifen by progestrerone in the 7, 12 dimethylbenzanthracene induced rat memmary carcinoma model" Abstr. No. 6406296, Cancer Res. 47(20)5386-5390.
Scisearch JZ430, issued 1992, Jeng et al. "Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation" Abstr. No. 11952719, Cancer Research 52(23), 6539-6546.
Bundgaard, "Design of Prodrugs" published 1985, by Elsevier (N.Y.) see pp. 3, 8, 9.
Frolik, et al., "In Vivo and In Vitro Metabolism of Raloxifene," Am. Soc. Bone & Min. Res., Tampa, Sep. 18-22, 1993.
Lindstrom, et al., "Disposition and Metabolism of New Benzothiophene Antiestrogen in Rats, Dogs, Monkeys," Xenobiotica, 14(11), pp. 841-847 (1984).
Jones, et al., "Antiestrogens. 2. Structure-Activity Studies in a Series of ethoxy!-phenyl!methanone Hydrochloride(LY156758), a Remarkably Effective Estrogen Antagonist with Only Minimal Intrinsic Estrogenicity", J. Med. Chem., 27, pp. 1057-1066 (1984).
Clay Michael Paul
Frolik Charles Alan
Jones Charles David
Lindstrom Terry Donald
Boone David E.
Eli Lilly and Company
Ngo Tamthom T.
Sales James J.
Shah Mukund J.
LandOfFree
Sulfated benzothiophene derivatives, methods of use and formulat does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sulfated benzothiophene derivatives, methods of use and formulat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfated benzothiophene derivatives, methods of use and formulat will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2396063